The overall standardised incidence ratio, adjusted for calendar year, and age and sex standardised to the reference population of each country, was higher in the ever TNFi-exposed versus biologic-naïve patients at 1.1 (95% CI 0.9, 1.4), but this did not reach statistical significance.
← all excerpts
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
1
—
—